Functional MR Imaging Evidence of Altered Functional Activation in Metabolic Syndrome

References

1. 1.↵
   The Silver Book: Chronic Disease and Medical Innovation in an Aging Nation. http://www.silverbook.org. Accessed 2007
2. 2.↵
   1. Gaugler JE,
   2. Yu F,
   3. Krichbaum K,
   4. et al

   . Predictors of nursing home admission for persons with dementia. Med Care 2009;47:191–98

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Athilingam P,
   2. King KB

   . Heart and brain matters in heart failure: a literature review. J N Y State Nurses Assoc 2007;38:13–19

   PubMed
4. 4.↵
   1. Erkinjuntti T,
   2. Roman G,
   3. Gauthier S,
   4. et al

   . Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke 2004;35:1010–17

   Abstract/FREE Full Text
5. 5.↵
   1. Erkinjuntti T

   . Diagnosis and management of vascular cognitive impairment and dementia. J Neural Transm Suppl 2002;91–109
6. 6.↵
   1. Farlow MR

   . Use of antidementia agents in vascular dementia: beyond Alzheimer disease. Mayo Clin Proc 2006;81:1350–58

   CrossRefPubMed
7. 7.↵
   1. Nyenhuis DL,
   2. Gorelick PB

   . Diagnosis and management of vascular cognitive impairment. Curr Atheroscler Rep 2007;9:326–32

   CrossRefPubMed
8. 8.↵
   1. Alberti KG,
   2. Eckel RH,
   3. Grundy SM,
   4. et al

   . Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640–45. Epub 2009 Oct 5

   Abstract/FREE Full Text
9. 9.↵
   1. Akbaraly TN,
   2. Kivimaki M,
   3. Shipley MJ,
   4. et al

   . Metabolic syndrome over 10 years and cognitive functioning in late midlife: the Whitehall II study. Diabetes Care 2010;33:84–89. Epub 2009 Oct 16

   Abstract/FREE Full Text
10. 10.↵
    1. Kalmijn S,
    2. Foley D,
    3. White L,
    4. et al

    . Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men: the Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol 2000;20:2255–60

    Abstract/FREE Full Text
11. 11.↵
    1. Yaffe K,
    2. Haan M,
    3. Blackwell T,
    4. et al

    . Metabolic syndrome and cognitive decline in elderly Latinos: findings from the Sacramento Area Latino Study of Aging study. J Am Geriatr Soc 2007;55:758–62

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Yaffe K,
    2. Weston AL,
    3. Blackwell T,
    4. et al

    . The metabolic syndrome and development of cognitive impairment among older women. Arch Neurol 2009;66:324–28

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Gatto NM,
    2. Henderson VW,
    3. St John JA,
    4. et al

    . Metabolic syndrome and cognitive function in healthy middle-aged and older adults without diabetes. Neuropsychol Dev Cog B Neuropsychol Cog 2008;15:627–41. Epub 2008 May 16
14. 14.↵
    1. Dik MG,
    2. Jonker C,
    3. Comijs HC,
    4. et al

    . Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 2007;30:2655–60

    Abstract/FREE Full Text
15. 15.↵
    1. Vanhanen M,
    2. Koivisto K,
    3. Moilanen L,
    4. et al

    . Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology 2006;67:843–47

    Abstract/FREE Full Text
16. 16.↵
    1. Raffaitin C,
    2. Gin H,
    3. Empana J-P,
    4. et al

    . Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study. Diabetes Care 2009;32:169–74

    Abstract/FREE Full Text
17. 17.↵
    1. Segura B,
    2. Jurado MA,
    3. Freixenet N,
    4. et al

    . Mental slowness and executive dysfunctions in patients with metabolic syndrome. Neurosci Lett 2009;462:49–53

    CrossRefPubMed
18. 18.↵
    1. Yaffe K

    . Metabolic syndrome and cognitive disorders: is the sum greater than its parts? Alzheimer Dis Assoc Disord 2007;21:167–71

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Bokura H,
    2. Yamaguchi S,
    3. Iijima K,
    4. et al

    . Metabolic syndrome is associated with silent ischemic brain lesions. Stroke 2008;39:1607–09

    Abstract/FREE Full Text
20. 20.↵
    1. Segura B,
    2. Jurado MA,
    3. Freixenet N,
    4. et al

    . Microstructural white matter changes in metabolic syndrome: a diffusion tensor imaging study. Neurology 2009;73:438–44

    Abstract/FREE Full Text
21. 21.↵
    1. Park K,
    2. Yasuda N,
    3. Toyonaga S,
    4. et al

    . Significant associations of metabolic syndrome and its components with silent lacunar infarction in middle aged subjects. J Neurol Neurosurg Psychiatry 2008;79:719–21

    Abstract/FREE Full Text
22. 22.↵
    1. Sweet LH,
    2. Rao SM,
    3. Primeau M,
    4. et al

    . Functional magnetic resonance imaging of working memory among multiple sclerosis patients. J Neuroimaging 2004;14:150–57

    PubMedWeb of Science
23. 23.↵
    1. Machulda MM,
    2. Ward HA,
    3. Borowski B,
    4. et al

    . Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology 2003;61:500–06

    Abstract/FREE Full Text
24. 24.↵
    1. Saykin AJ,
    2. Flashman LA,
    3. Frutiger SA,
    4. et al

    . Neuroanatomic substrates of semantic memory impairment in Alzheimer's disease: patterns of functional MRI activation. J Int Neuropsychol Soc 1999;5:377–92

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Chang L,
    2. Speck O,
    3. Miller EN,
    4. et al

    . Neural correlates of attention and working memory deficits in HIV patients. Neurology 2001;57:1001–07

    Abstract/FREE Full Text
26. 26.↵
    1. Bondi MW,
    2. Houston WS,
    3. Eyler LT,
    4. et al

    . fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 2005;64:501–08

    Abstract/FREE Full Text
27. 27.↵
    1. Filbey FM,
    2. Slack KJ,
    3. Sunderland TP,
    4. et al

    . Functional magnetic resonance imaging and magnetoencephalography differences associated with APOE ε4 in young healthy adults. Neuroreport 2006;17:1585–90

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Oldfield RC

    . The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971;9:97–113

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Wechsler D

    . Wechsler Abbreviated Scale of Intelligence Manual. San Antonio, Texas: Harcourt Assessment Company; 1999
30. 30.↵
    1. Lezak MD

    . Neuropsychological Assessment. New York: Oxford University Press; 1995
31. 31.↵
    1. Folstein MF,
    2. Folstein SE,
    3. McHugh PR

    . “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Morris JC,
    2. Heyman A,
    3. Mohs RC,
    4. et al

    . The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159–65

    Abstract/FREE Full Text
33. 33.↵
    1. Delis DC,
    2. Kramer JH,
    3. Kaplan E,
    4. et al

    . California Verbal Learning Test (CVLT-II) Manual. San Antonio, Texas: Harcourt Assessment Company; 2000
34. 34.↵
    1. Lewis RF

    . Digit Vigilance Test. Odessa, California: Psychological Assessment Resources; 1995
35. 35.↵
    1. Eslinger P

    . The Iowa Screening Battery for Mental Decline. Iowa City, Iowa: University of Iowa College of Medicine; 1984
36. 36.↵
    1. Reitan R

    . Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271–76

    CrossRef
37. 37.↵
    1. Klove H,
    2. Forster FM

    . Clinical neuropsychology. In: The Medical Clinics of North America. New York: Saunders; 1963
38. 38.↵
    1. Beck AT,
    2. Steer RA,
    3. Brown GK

    . BDI-II Manual. Fort Worth, Texas: The Psychological Corporation; 1996
39. 39.↵
    1. Cox RW

    . AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 1996;29:162–73

    CrossRefPubMedWeb of Science
40. 40.↵
    1. Haley AP,
    2. Sweet LH,
    3. Gunstad J,
    4. et al

    . Verbal working memory and atherosclerosis in patients with cardiovascular disease: an fMRI study. J Neuroimaging 2007;17:227–33

    CrossRefPubMed
41. 41.↵
    1. Talairach J,
    2. Tournoux P

    . Co-Planar Stereotaxic Atlas of the Human Brain 3-D Proportional System: An Approach to Cerebral Imaging. New York: Thieme Medical Publishers; 1988
42. 42.↵
    1. Ravizza SM,
    2. Delgado MR,
    3. Chein JM,
    4. et al

    . Functional dissociations within the inferior parietal cortex in verbal working memory. Neuroimage 2004;22:562–73

    CrossRefPubMedWeb of Science
43. 43.↵
    1. Haley AP,
    2. Forman DE,
    3. Poppas A,
    4. et al

    . Carotid artery intima-media thickness and cognition in cardiovascular disease. Int J Cardiol 2007;121:148–54

    CrossRefPubMed
44. 44.↵
    1. Cohen RA,
    2. Poppas A,
    3. Forman DE,
    4. et al

    . Vascular and cognitive functions associated with cardiovascular disease in the elderly. J Clin Exp Neuropsychol 2009;31:96–110

    PubMed
45. 45.↵
    1. Forman DE,
    2. Cohen RA,
    3. Hoth KF,
    4. et al

    . Cognition and brachial endothelial responses in older adults with cardiovascular disease. Artery Research 2008;2:35–43. Epub 2008 Jun 16

    CrossRefPubMed
46. 46.↵
    1. Brookheimer SY,
    2. Stojwas MH,
    3. Cohen MS,
    4. et al

    . Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 2000;343:450–56

    CrossRefPubMedWeb of Science
47. 47.↵
    1. Sweet LH,
    2. Rao SM,
    3. Primeau M,
    4. et al

    . Functional magnetic resonance imaging response to increased verbal working memory demands among patients with multiple sclerosis. Hum Brain Mapp 2006;27:28–36

    CrossRefPubMedWeb of Science
48. 48.↵
    1. Gonzales MM,
    2. Tarumi T,
    3. Tanaka H,
    4. et al

    . Functional imaging of working memory and peripheral endothelial function in middle-aged adults. Brain Cogn 2010;73:146–51

    CrossRefPubMed
49. 49.↵
    1. Haley AP,
    2. Gunstad J,
    3. Cohen RA,
    4. et al

    . Neural correlates of visuospatial working memory in healthy young adults at risk for hypertension. Brain Imaging Behav 2008;2:192–99

    CrossRef
50. 50.↵
    1. Irani F,
    2. Sweet L,
    3. Haley A,
    4. et al

    . An fMRI study of verbal working memory, cardiac output, and ejection fraction in elderly patients with cardiovascular disease. Brain Imaging Behav 2009;3:350–57

    CrossRef
51. 51.↵
    1. Gunstad J,
    2. Cohen RA,
    3. Tate DF,
    4. et al

    . Blood pressure variability and white matter hyperintensities in older adults with cardiovascular disease. Blood Press 2005;14:353–58

    CrossRefPubMed
52. 52.↵
    1. Hoth KF,
    2. Tate DF,
    3. Poppas A,
    4. et al

    . Endothelial function and white matter hyperintensities in older adults with cardiovascular disease. Stroke 2007;38:308–12. Epub 2007 Jan 4

    Abstract/FREE Full Text
53. 53.↵
    1. Jefferson AL,
    2. Tate DF,
    3. Poppas A,
    4. et al

    . Lower cardiac output is associated with greater white matter hyperintensities in older adults with cardiovascular disease. J Am Geriatr Soc 2007;55:1044–48

    CrossRefPubMedWeb of Science
54. 54.↵
    1. Jefferson AL,
    2. Poppas A,
    3. Paul RH,
    4. et al

    . Systemic hypoperfusion is associated with executive dysfunction in geriatric cardiac patients. Neurobiol Aging 2007;28:477–83

    CrossRefPubMedWeb of Science
55. 55.↵
    1. Paul RH,
    2. Gunstad J,
    3. Poppas A,
    4. et al

    . Neuroimaging and cardiac correlates of cognitive function among patients with cardiac disease. Cerebrovasc Dis 2005;20:129–33

    PubMed
56. 56.↵
    1. Sachdev P,
    2. Chen X,
    3. Wen W

    . White matter hyperintensities in mid-adult life. Curr Opin Psychiatry 2008;21:268–74

    CrossRefPubMed